TMH sells needle-free insulin biz
The Medical House (TMH) has sold its SQ-PEN needle-free insulin injector business as it moves away from supplying the product to private individuals to focus more on its drug delivery systems business.
The Medical House (TMH) has sold its SQ-PEN needle-free insulin injector business as it moves away from supplying the product to private individuals to focus more on its drug delivery systems business.
US researchers have developed a nanogel drug delivery system which has the potential for controlled release activity and targeted drug delivery.
Swiss firm Novartis has gained US approval of its once-yearly treatment for postmenopausal osteoporosis, with EU approval expected to follow hot on its heels.
Through a new service partnership, Applied Biosystems is helping scientists study genetic variations - even if they can't access or afford the necessary lab equipment.
Quintiles, PPD, Premier Research, PharmEng and WuXi PharmaTech have all had people on the move in the world of pharmaceutical outsourcing.
Solvay Pharmaceuticals still believed it was on track for meeting US regulatory deadlines for pancreatic insufficiency drugs despite receiving an approvable letter for its own newly formulated drug Creon.